Skip to main content
Search

# Drug target assessment

1 related articles

Subscribe to updates
  1. Incyte hands target assessment to Kosmos TA: one workday per target, and 83% of de-risking experiments match committee requests

    Incyte and Edison Scientific built Kosmos TA, a target-assessment version of the Kosmos AI scientist that continuously assembles literature, patents and other sources and brings safety, tractability and competitive intelligence into the package earlier. In a retrospective comparison scored against a rubric built from Incyte target-review meeting transcripts, Kosmos TA scored consistently higher than human-prepared assessments, with the largest gains outside the core biological rationale; on six targets with known committee decisions, 83% of its proposed de-risking experiments were a perfect or conceptual match to the experiments the committee actually requested.

You’re all caught up